The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study

The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study

Rituximab is used to eliminate B cells as a chimeric monoclonal antibody directed against CD20, a B-cell antigen expressed on B cells. To explore the impact of rituximab administered before transplantation, we implemented a retrospective, monocentric study and utilized real-world data collected at o...

Full description

Bibliographic Details
Main Authors:	Xiya Wei, Yiyu Xie, Ruoyu Jiang, Huiyu Li, Heqing Wu, Yuqi Zhang, Ling Li, Shiyuan Zhou, Xiao Ma, Zaixiang Tang, Jun He, Depei Wu, Xiaojin Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Immunology
Subjects:	rituximab B cell prior to transplantation allogeneic hematopoietic stem cell transplantation EBV - Epstein-Barr virus aGVHD: acute graft vs host disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.967026/full

Similar Items

Screening and clinical significance of intestinal colonization of carbapenem-resistant Enterobacteriaceae (CRE) in patients before haploidentical hematopoietic stem cell transplantation
by: Wenqi WU, et al.
Published: (2023-06-01)

Identification of Heme Oxygenase-1 as a Novel Predictor of Hematopoietic Stem Cell Transplantation Outcomes in Acute Leukemia
by: Yinghao Lu, et al.
Published: (2016-09-01)

The role of animal models in the study of hematopoietic stem cell transplantation and GvHD: A historical overview.
by: Margherita Boieri, et al.
Published: (2016-08-01)

Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
by: Xiaoyu Zhang, et al.
Published: (2022-12-01)

Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review
by: Abhinav Bhattarai, et al.
Published: (2024-12-01)

Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
by: Huimin Sun, et al.
Published: (2024-09-01)

Application prospect of low-dose porcine anti-thymocyte globulin in HLA-matched sibling donor transplantation
by: Xin Chen, et al.
Published: (2023-12-01)

Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
by: A Ghavamzadeh, et al.
Published: (2004-03-01)

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
by: Shabnam Shokouhi, et al.
Published: (2015-09-01)

Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS in vitro and correlates with inflammatory parameters and clinical severity
by: Bernardo López-Andrade, et al.
Published: (2024-03-01)

Influence of SPIO labelling on the function of BMSCs in chemokine receptors expression and chemotaxis
by: Yuanchun Liu, et al.
Published: (2023-06-01)

Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome
by: Xiaoqing Li, et al.
Published: (2020-11-01)

Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD
by: Yin Liu, et al.
Published: (2022-11-01)

Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donors
by: Lingling Liu, et al.
Published: (2022-09-01)

Clinical outcomes and early immune reconstitution in patients with acute lymphoblastic leukemia underwent allogeneic hematopoietic stem cell transplantation
by: Huiyu LI, et al.
Published: (2023-09-01)

Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease—an analysis from transplant centers across Europe
by: Ronja Langer, et al.
Published: (2024-03-01)

Tissue-specific expression patterns of microRNA during acute graft-versus-host disease in the rat.
by: Dasaradha Jalapothu, et al.
Published: (2016-09-01)

Dysregulated Expression of CD28 and CTLA-4 Molecules in Patients with Acute Myeloid Leukemia and Possible Association with Development of Graft <em>versus</em> Host Disease after Hematopoietic Stem Cell Transplantation
by: M Ramzi, et al.
Published: (2019-05-01)

ORAL GRAFT VERSUS HOST DISEASE: A REVIEW
by: Reddy Lavanya, et al.
Published: (2016-03-01)

Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation
by: Balaji Balakrishnan, et al.
Published: (2020-07-01)

Dual roles of CD11b+CD33+HLA-DR-/lowCD14- myeloid-derived suppressor cells with a granulocytic morphology following allogeneic hematopoietic stem cell transplantation: from inflammation promoters to immune suppressors within 90 days
by: Ming Ni, et al.
Published: (2024-07-01)

Graft immune cell composition associates with clinical outcome of allogeneic hematopoietic stem cell transplantation in patients with AML
by: Ulla Impola, et al.
Published: (2016-11-01)

Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study
by: Lu Gao, et al.
Published: (2024-01-01)

Strategies in Haploidentical Stem Cell Transplantation in Adults
by: Ulaş D. Bayraktar, et al.
Published: (2013-12-01)

The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation
by: Qingyuan Zheng, et al.
Published: (2021-04-01)

Allogeneic hematopoietic stem cell transplantation in non‐Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better
by: Ekaterina Rebmann, et al.
Published: (2023-02-01)

Downregulation of p53 by Insufficient CTCF in CD4+ T Cells Is an Important Factor Inducing Acute Graft-Versus-Host Disease
by: Juan Hua, et al.
Published: (2020-09-01)

Tacrolimus Induced Diabetic Ketoacidosis Following Allogeneic Stem Cell Transplantation
by: Sanjeev Kumar Sharma, et al.
Published: (2014-08-01)

A Possible Reason to Induce Acute Graft-vs.-Host Disease After Hematopoietic Stem Cell Transplantation: Lack of Sirtuin-1 in CD4+ T Cells
by: Ya-jing Xu, et al.
Published: (2018-12-01)

Diagnosis and treatment of passenger lymphocyte syndrome following secondary ABO-incompatible allogeneic hematopoietic stem cell transplantation
by: Yingchun SHAO, et al.
Published: (2023-11-01)

Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) – Case series
by: Ashley N. Gray, et al.
Published: (2023-05-01)

Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy
by: Anna Robuccio, et al.
Published: (2015-01-01)

miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
by: Mahdiyar Iravani Saadi, et al.
Published: (2023-06-01)

Chronic Graft versus Host Disease after Allogeneic Bone Marrow Transplantation; An Analysis of Incidence and Risk Factors.
by: A Ghavamzadeh, et al.
Published: (2004-03-01)

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
by: B. Linder Grønvold, et al.
Published: (2024-02-01)

Correlation of IL-6 and IL-10 production following bone marrow transplantation with donor cytokine gene polymorphisms Correlação da produção de IL-6 e IL-10 seguindo o transplante de medula óssea com os polimorfismos de genes de citocinas do doador
by: Jeane E. L. Visentainer, et al.
Published: (2008-12-01)

Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons
by: Mehdi Mohammadi, et al.
Published: (2016-04-01)

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
by: Elizabeth Stenger, et al.
Published: (2022-09-01)

Large granular lymphocytic leukemia cured by allogeneic stem cell transplant: a case report
by: Edward Carey, et al.
Published: (2022-06-01)

4SCAR2.0 therapy for the management of post-transplantation relapse of B-cell acute lymphoblastic leukemia
by: Rui Zhang, et al.
Published: (2023-11-01)